Canaccord Genuity Reiterates a Buy Rating on Kenvue Inc. (KVUE)

Group 1 - Kenvue Inc. (NYSE:KVUE) is considered one of the best affordable stocks to buy under $20, with a Buy rating and a price target of $26 set by Canaccord Genuity analyst Susan Anderson [1] - The company is facing legal challenges related to talc lawsuit liabilities in the UK, but the analyst believes that a judge-led legal system may result in lower financial liabilities compared to the US [2][3] - Kenvue Inc. is expected to contest the lawsuit vigorously, utilizing scientific data to support the safety of its talc-based products [3] Group 2 - Kenvue operates through three segments: Skin Health and Beauty, Self Care, and Essential Health, with a global presence in over 165 countries [4]